Frontiers in Immunology (Jun 2022)
T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG
- Luis Romero-Martín,
- Luis Romero-Martín,
- Ferran Tarrés-Freixas,
- Núria Pedreño-López,
- Maria L. Rodríguez de la Concepción,
- Francesc Cunyat,
- Dennis Hartigan-O'Connor,
- Dennis Hartigan-O'Connor,
- Dennis Hartigan-O'Connor,
- Jorge Carrillo,
- Jorge Carrillo,
- Beatriz Mothe,
- Beatriz Mothe,
- Beatriz Mothe,
- Beatriz Mothe,
- Julià Blanco,
- Julià Blanco,
- Julià Blanco,
- Marta Ruiz-Riol,
- Marta Ruiz-Riol,
- Christian Brander,
- Christian Brander,
- Christian Brander,
- Christian Brander,
- Alex Olvera,
- Alex Olvera,
- Alex Olvera
Affiliations
- Luis Romero-Martín
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Luis Romero-Martín
- Departament de Biologia Cellular, de Fisiologia i d’Immunologia, Universitat Autonoma de Barcelona, Cerdanyola del Valles, Spain
- Ferran Tarrés-Freixas
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Núria Pedreño-López
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Maria L. Rodríguez de la Concepción
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Francesc Cunyat
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Dennis Hartigan-O'Connor
- Department of Medical Microbiology and Immunology, University of California, Davis, Davis, CA, United States
- Dennis Hartigan-O'Connor
- California National Primate Research Center, University of California, Davis, Davis, CA, United States
- Dennis Hartigan-O'Connor
- Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States
- Jorge Carrillo
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Jorge Carrillo
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Beatriz Mothe
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Beatriz Mothe
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Beatriz Mothe
- University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
- Beatriz Mothe
- Fundació Lluita contra la Sida, Infectious Disease Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
- Julià Blanco
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Julià Blanco
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Julià Blanco
- University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
- Marta Ruiz-Riol
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Marta Ruiz-Riol
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Christian Brander
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Christian Brander
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Christian Brander
- Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
- Christian Brander
- 0AELIX Therapeutics, Barcelona, Spain
- Alex Olvera
- IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain
- Alex Olvera
- CIBERINFEC, Centro de Investigación Biomédica en Red, Instituto de salud Carlos III, Madrid, Spain
- Alex Olvera
- University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain
- DOI
- https://doi.org/10.3389/fimmu.2022.928039
- Journal volume & issue
-
Vol. 13
Abstract
T cell responses are considered critical for the in vivo control of HIV, but the contribution of different T cell subsets to this control remains unclear. Using a boosted flow cytometric approach that is able to differentiate CD4+ and CD8+ T cell Th1/Tc1, Th2/Tc2, Th17/Tc17, Treg and Tfh/Tfc-like HIV-specific T cell populations, we identified CD8+ Tfc responses that were related to HIV plasma viral loads and associated with rate of antibody isotype class switching to IgG. This favorable balance towards IgG responses positively correlated with increased virus neutralization, higher avidity of neutralizing antibodies and more potent antibody-dependent cell cytotoxicity (ADCC) in PBMCs from HIV controllers compared to non-controllers. Our results identified the CD8+ Tfc-like T-cell response as a component of effective virus control which could possibly be exploited therapeutically.
Keywords
- HIV
- humoral immune response
- human immunodeficiency virus (HIV) control
- T-follicular cytotoxic (Tfc) cells
- viral control